Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Hospitalier Universitaire De Toulouse
Sponsor

Centre Hospitalier Universitaire De Toulouse

France 2 Rue Viguerie, 31300 Toulouse, France

About the sponsor

The sponsor supports clinical research in ANCA-associated vasculitis, rheumatoid arthritis, systemic sclerosis, systemic scleroderma, immune thrombocytopenia, mastocytosis, and autoimmune encephalitis, with additional interest in Buerger's disease and critical limb ischemia.

  • ANCA-associated vasculitis
  • Rheumatoid arthritis
  • Systemic sclerosis
  • Autoimmune encephalitis
  • Immune thrombocytopenia

Its research also includes immune-mediated skin and vascular disorders, alongside studies of inflammatory symptom control and immune response modulation.

About Specializations

Centre Hospitalier Universitaire De Toulouse runs clinical trials in conditions such as Parkinson's disease, Systemic scleroderma, Subarachnoid haemorrhage, Cerebrovascular accident, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

36 clinical trials

Encephalitis autoimmune

Recruiting

Testing 18F-DPA-714 PET scan as a marker of brain inflammation in patients with autoimmune encephalitis

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:N,N-DIETHYL-(2-(4-(2-(18F)FLUOROETHOXY)PHENYL)-5,7-DIMETHYLPYRAZOLO(1,5-A)PYRIMIDINE-3-YL)ACETAMIDE
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Systemic scleroderma

Recruiting

Study of adipose-derived mesenchymal stem cell injections to treat mouth fibrosis in patients with systemic scleroderma

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Albumin
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Rheumatic disorder

Recruiting

Study on Immune Response to Recombinant Zoster Vaccine in Rheumatic Disease Patients Using Baricitinib, Tofacitinib, or Methotrexate

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Endometriosis

Recruiting

Study on Using Fluoroestradiol F-18 PET/CT for Detecting Endometriosis in Patients with Pain

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Fluoroestradiol F-18
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Asthma

Recruiting

Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Analgesic therapy

Recruiting

Study on Betamethasone Injection for Pain Relief in Adults with Degenerative Meniscal Injury

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Parkinson's disease

Recruiting

Study on Amantadine for Reducing Motor Fluctuations in Advanced Parkinson's Disease Patients

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amantadine Hydrochloride
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Subarachnoid haemorrhage

Recruiting

Study on Milrinone for Preventing Delayed Brain Ischemia in Patients with Severe Subarachnoid Hemorrhage

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Dementia Alzheimer's type

Recruiting

Study on Alzheimer's Disease Using Flortaucipir (18F) for Early Diagnosis in At-Risk Patients

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Flortaucipir (18F)
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Osteoporosis postmenopausal

Recruiting

Study on Zoledronic Acid Use After Stopping Denosumab in Women with Postmenopausal Osteoporosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Zoledronic Acid
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Ichthyosis

Recruiting

Study on the Effects of Injectable Gentamicin for Patients with Moderate to Severe Congenital Ichthyosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gentamicin Sulfate
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Rheumatoid arthritis

Recruiting

Study on Reducing JAK Inhibitor Doses in Patients with Low Disease Activity in Rheumatoid Arthritis Using Tofacitinib and Drug Combination

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.